Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to see which one of two medicines (topical gentian violet [GV]
or nystatin oral suspension) was better than the other in treating Oral Candidiasis (OC).
This was measured by whether the study participant still had OC or sores in his/her mouth
after 14 days of treatment. Also, safety and tolerability of GV and nystatin in the treatment
of OC were assessed.
Phase:
Phase 3
Details
Lead Sponsor:
AIDS Clinical Trials Group
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)